MARINUS PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Marinus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Marinus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $700K, a 36.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $700K -$400K -36.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.5M +$300K +25% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1M -$300K -23.1% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $1M -$400K -28.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.1M -$400K -26.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.2M -$400K -25% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.3M -$400K -23.5% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $1.4M -$300K -17.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1.5M -$300K -16.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.6M -$300K -15.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.7M -$300K -15% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.7M -$300K -15% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.8M -$300K -14.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $1.9M -$300K -13.6% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2M -$200K -9.09% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $2M -$300K -13% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.1M -$300K -12.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.2M -$200K -8.33% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $2.2M -$300K -12% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $2.3M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $2.4M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.4M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $2.5M Jan 1, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.